Iwamura Yoshihiro, Fujii Yoko, Kamei Chiaki
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Okayama University, Japan.
J Pharmacol Sci. 2004 Mar;94(3):271-6. doi: 10.1254/jphs.94.271.
The present study was undertaken to clarify the effects of selective serotonin-reuptake inhibitors (SSRIs) on visual evoked potential (VEP) in rats. To elucidate the mechanism of action of SSRIs, some serotonin (5-HT) agonists were used. SSRIs, fluvoxamine and paroxetine, caused a reduction in the amplitudes of P1-N1, P3-N3, and N3-P4 components of VEP. The amplitude of the P1-N1 component was also reduced by the 5-HT1A agonist 8-OH-DPAT and 5-HT1B agonist anpirtoline. On the other hand, amplitudes of P3-N3 and N3-P4 components were reduced by anpirtoline and the 5-HT2 agonist DOI. These results indicate that the reduction in the amplitude of the P1-N1 component of VEP induced by SSRIs may participate in 5-HT1A and 5-HT1B receptors, and those of P3-N3 and N3-P4 components induced by SSRIs may be closely related with 5-HT1B and 5-HT2 receptors.
本研究旨在阐明选择性5-羟色胺再摄取抑制剂(SSRIs)对大鼠视觉诱发电位(VEP)的影响。为了阐明SSRIs的作用机制,使用了一些5-羟色胺(5-HT)激动剂。SSRIs、氟伏沙明和帕罗西汀导致VEP的P1-N1、P3-N3和N3-P4成分的波幅降低。5-HT1A激动剂8-OH-DPAT和5-HT1B激动剂安匹托林也使P1-N1成分的波幅降低。另一方面,安匹托林和5-HT2激动剂DOI使P3-N3和N3-P4成分的波幅降低。这些结果表明,SSRIs诱导的VEP的P1-N1成分波幅降低可能与5-HT1A和5-HT1B受体有关,而SSRIs诱导的P3-N3和N3-P4成分波幅降低可能与5-HT1B和5-HT2受体密切相关。